Ethiopia: Promising Patient-Friendly Oral Drug Against Visceral Leishmaniasis Enters Phase II Clinical Trial in Ethiopia

[WHO] The new molecule has the potential to revolutionize treatment for the deeply neglected and hard-to-treat disease, as the Eastern Africa region charts the way to its elimination.
Source: AllAfrica News: Health and Medicine - Category: African Health Tags: East Africa Ethiopia External Relations Health and Medicine International Organizations and Africa Source Type: news